Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: The Japan diabetes complications study (JDCS)

Diabetologia

Volumn 54, Issue 5, 2011, Pages 1025-1031

  Katayama, S ^a   Moriya, T ^b   Tanaka, S ^c,d   Yajima, Y ^b   Sone, H ^e   Iimuro, S ^f   Ohashi, Y ^f   Akanuma, Y ^g   Yamada, N ^e  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d TOKYO UNIVERSITY OF SCIENCE   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g INSTITUTE FOR ADULT DISEASES   (Japan)

Author keywords

Blood pressure; Diabetic nephropathy; Glycaemic control; Progression; Remission; Smoking

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; REMISSION; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEINURIA;

EID: 79954628786     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-2025-0     Document Type: Article

References (21)

1. E Ritz S Orth 1999 Nephropathy in patients with type 2 diabetes mellitus N Engl J Med 341 1127 1133 10511612 10.1056/NEJM199910073411506 1:STN:280:DyaK1Mvis1Grug%3D%3D (Pubitemid 29466226)
2. MI Caramori P Fioretto M Mauer 2000 The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 49 1399 1408 10969821 10.2337/diabetes.49.9.1399 1:CAS:528:DC%2BD3cXmsVOrs7Y%3D
3. Statistic Committee of Japan Hemodialysis Society 2009 An overview of dialysis treatment in Japan (as of December 31, 2007) J Jpn Hemodialysis Soc 42 1 45 10.4009/jsdt.42.1 (article in Japanese)
4. AI Adler RJ Stevens SE Manley RW Bilous CA Cull RR Holman 2003 Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64) Kidney Int 63 225 232 12472787 10.1046/j.1523-1755.2003.00712.x (Pubitemid 35463925)
5. SF Lui YW Ho KF Chu CB Leung BY Choy 1999 Hong Kong registry 1995-1999 Hong Kong J Nephrol 1 53 60 10.1016/S1561-5413(09)60020-X
6. H Makino M Haneda T Babazono, et al. 2007 Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes Diabetes Care 30 1577 1578 17389334 10.2337/dc06-1998 1:CAS:528: DC%2BD2sXntlWkt7g%3D (Pubitemid 46871174)
7. JCN Chan NMS Wat W-Y So, et al. 2004 Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study Diabetes Care 27 874 879 15047641 10.2337/diacare.27.4.874 1:CAS:528:DC%2BD2cXjsFegsrw%3D (Pubitemid 38420207)
8. H Sone A Katagiri S Ishibashi, et al. 2002 Effects of lifestyle modifications on patients with type 2 diabetes: the Japan Diabetes Complications Study (JDCS) study design, baseline analysis and three-year interim report Horm Metab Res 34 509 515 12384828 10.1055/s-2002-34791 1:CAS:528: DC%2BD38Xotlahs7g%3D (Pubitemid 35192238)
9. H Sone S Tanaka S Iimuro, et al. 2010 Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicenter randomized controlled trial (the Japan Diabetes Complications Study) Diabetologia 53 419 428 20054522 10.1007/s00125-009-1622-2 1:STN:280:DC%2BC3c7gsVGqtw%3D%3D
10. S Matsuo E Imai M Horio, et al. 2009 Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 982 992 19339088 10.1053/j.ajkd.2008.12.034 1:CAS:528:DC%2BD1MXnslKku7c%3D
11. M Ravid D Brosh D Ravid-Safran Z Levy R Rachmani 1998 Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia Arch Intern Med 159 998 1004 10.1001/archinte.158.9.998 (Pubitemid 28213577)
12. RG Nelson WC Knowler DJ Pettitt RL Hanson PH Benett 1995 Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM Diabetes Care 18 182 187 7729295 10.2337/diacare.18.2.182 1:STN:280: DyaK2M3ks1Gruw%3D%3D
13. H Yokoyama M Okudaira T Otani, et al. 1998 High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients Diabetes Care 21 1080 1085 9653599 10.2337/diacare.21.7.1080 1:STN:280:DyaK1czhslCrsw%3D%3D (Pubitemid 28368512)
14. S Araki M Haneda T Sugimoto, et al. 2005 Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes Diabetes 54 2983 2987 16186402 10.2337/diabetes.54.10.2983 1:CAS:528:DC%2BD2MXhtV2rs7zN (Pubitemid 41401096)
15. R Retnakaran CA Cull KI Thorne AI Adler RR Holman 2006 Risk factors for renal dysfunction in type 2 diabetes. U.K. Prospective Diabetes Study 74 Diabetes 55 1832 1839 16731850 10.2337/db05-1620 1:CAS:528:DC%2BD28Xlsl2gu7w%3D (Pubitemid 44324140)
16. The Diabetes Control and Complications Trial Research Group 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 977 986 10.1056/NEJM199309303291401 (Pubitemid 23307905)
17. Y Okubo M Shichiri H Kishikawa, et al. 1995 Intensive insulin therapy prevents the progression of diabetic microvascular complication in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study Diab Res Clin Pract 28 103 117 10.1016/0168-8227(95)01064-K
18. UK Prospective Diabetes Study (UKPDS) Group 1998 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837 853 10.1016/S0140-6736(98)07019-6 (Pubitemid 28416718)
19. EJ Lewis LG Hunsicker RP Bain RD Rohde 1993 The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. The Collaborative Study Group N Engl J Med 329 1456 1462 8413456 10.1056/NEJM199311113292004 1:STN:280:DyaK2c%2FhvFKitQ%3D%3D (Pubitemid 23335891)
20. BM Brenner ME Cooper D de Zeeuw, et al. 2001 Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 861 869 11565518 10.1056/NEJMoa011161 1:CAS:528: DC%2BD3MXntlelsLk%3D
21. EJ Lewis LG Hunsicker WR Clarke, et al. 2001 Renoprotective effect of the angiotensin receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 851 860 11565517 10.1056/NEJMoa011303 1:CAS:528:DC%2BD3MXntlelsLg%3D